Copyright
©The Author(s) 2024.
World J Clin Oncol. Apr 24, 2024; 15(4): 496-522
Published online Apr 24, 2024. doi: 10.5306/wjco.v15.i4.496
Published online Apr 24, 2024. doi: 10.5306/wjco.v15.i4.496
Figure 2 Overview of immune dysregulation similarities between on endometriosis and ovarian cancer.
IL-1: Interleukin-1; IL-1B: Interleukin-1β; IL-4: Interleukin-4; IL-6: Interleukin-6; IL-8: Interleukin-8; IL-10: Interleukin-10; E2: Prostaglandin E2; ER-a: Estrogen Receptor Alpha; M1/M2: Macrophages; NK: Natural killer cell; TAM: Tumor-associated macrophages; Th1/Th2/Th17: T helper cells; TNF: Tumor Necrosis Factor; TNF-a: Tumor Necrosis Factor Alpha; TNF-B: Tumor Necrosis Factor Beta; ROS: Reactive oxygen species; VEGF: Vascular endothelial growth factor.
- Citation: Calmon MS, Lemos FFB, Silva Luz M, Rocha Pinheiro SL, de Oliveira Silva LG, Correa Santos GL, Rocha GR, Freire de Melo F. Immune pathway through endometriosis to ovarian cancer. World J Clin Oncol 2024; 15(4): 496-522
- URL: https://www.wjgnet.com/2218-4333/full/v15/i4/496.htm
- DOI: https://dx.doi.org/10.5306/wjco.v15.i4.496